These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3088629)

  • 1. Central muscarinic effects of physostigmine on mood, cardiovascular function, pituitary and adrenal neuroendocrine release.
    Janowsky DS; Risch SC; Kennedy B; Ziegler M; Huey L
    Psychopharmacology (Berl); 1986; 89(2):150-4. PubMed ID: 3088629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Centrally active antimuscarinic analogs of oxotremorine selectively block physostigmine-induced hypertension, but not peripheral muscarinic vasodepression.
    Vargas HM; Ringdahl B
    J Pharmacol Exp Ther; 1990 Apr; 253(1):165-70. PubMed ID: 2329503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of cholinergic regulation of vasopressin and norepinephrine responses to hypertonic saline in humans.
    Pascualy M; Peskind ER; Wingerson D; van Belle G; Veith RC; Dorsa DM; Raskind MA
    Psychoneuroendocrinology; 1995; 20(7):679-91. PubMed ID: 8848515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physostigmine reversal of scopolamine-induced hypofrontality.
    Prohovnik I; Arnold SE; Smith G; Lucas LR
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):220-8. PubMed ID: 9040502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central and peripheral cholinesterase inhibition: effects on anterior pituitary and sympathomimetic function.
    Risch SC; Janowsky DS; Mott MA; Gillin JC; Kalir HH; Huey LY; Ziegler M; Kennedy B; Turken A
    Psychoneuroendocrinology; 1986; 11(2):221-30. PubMed ID: 3018822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chin rub CRs are elicited by flavors associated with apomorphine, scopolamine, methscopolamine, physostigmine and neostigmine.
    Smith RJ; Parker LA
    Pharmacol Biochem Behav; 1985 Oct; 23(4):583-9. PubMed ID: 4070336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscarinic versus nicotinic modulation of a visual task. a pet study using drug probes.
    Mentis MJ; Sunderland T; Lai J; Connolly C; Krasuski J; Levine B; Friz J; Sobti S; Schapiro M; Rapoport SI
    Neuropsychopharmacology; 2001 Oct; 25(4):555-64. PubMed ID: 11557169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physostigmine challenge before and after chronic cholinergic blockade in elderly volunteers.
    Dukoff R; Wilkinson CW; Lasser R; Friz J; Conway A; Bahro M; Peskind ER; Sunderland T
    Biol Psychiatry; 1999 Jul; 46(2):189-95. PubMed ID: 10418693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of scopolamine, physostigmine and chlordiazepoxide on punished and extinguished water consumption in rats.
    Miczek KA; Lau P
    Psychopharmacologia; 1975 Jun; 42(3):263-9. PubMed ID: 1161984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An analysis of the respiratory stimulant effect of physostigmine and neostigmine in the conscious rabbit.
    Weinstock M; Roll D; Zilberman Y
    Clin Exp Pharmacol Physiol; 1981; 8(2):151-8. PubMed ID: 6788414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central cardiovascular effects of physostigmine in anesthetized cats.
    Hara Y; Ally A; Murayama S
    Neuropharmacology; 1992 Sep; 31(9):923-8. PubMed ID: 1436399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Depressive effects of physostigmine].
    Modestin J; Hunger J; Schwartz RB
    Arch Psychiatr Nervenkr (1970); 1973 Nov; 218(1):67-77. PubMed ID: 4588939
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of anti-cholinergic and cholinergic drugs on habituation to motion in rats.
    Morita M; Takeda N; Hasegawa S; Yamatodani A; Wada H; Sakai S; Kubo T; Matsunaga T
    Acta Otolaryngol; 1990; 110(3-4):196-202. PubMed ID: 2239207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of methscopolamine, physostigmine, and neostigmine on neuron activity in the midbrain, the hippocampus, and the hypothalamus in the behaving rat.
    Olds ME; Eibergen R
    Brain Res; 1973 Feb; 50(2):315-30. PubMed ID: 4705501
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular effects elicited by central administration of physostigmine via M2 muscarinic receptors in conscious cats.
    Ally A; Wilson LB; Nóbrega AC; Mitchell JH
    Brain Res; 1995 Apr; 677(2):268-76. PubMed ID: 7552252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central and peripheral muscarinic actions of physostigmine and oxotremorine on avoidance responding of squirrel monkeys.
    Witkin JM
    Psychopharmacology (Berl); 1989; 97(3):376-82. PubMed ID: 2497488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central cardiovascular effects of physostigmine in humans.
    Janowsky DS; Risch SC; Huey LY
    Hypertension; 1985; 7(1):140-5. PubMed ID: 3980055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sexually diergic hypothalamic-pituitary-adrenal axis responses to selective and non-selective muscarinic antagonists prior to cholinergic stimulation by physostigmine in rats.
    Smail MA; Soles JL; Karwoski TE; Rubin RT; Rhodes ME
    Brain Res Bull; 2018 Mar; 137():23-34. PubMed ID: 29122691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of azaprophen, scopolamine and trihexyphenidyl on schedule-controlled behavior, before and after chronic physostigmine.
    Genovese RF
    Eur J Pharmacol; 1990 Feb; 176(3):271-9. PubMed ID: 2328755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinociception opioids and the cholinergic system.
    Green PG; Kitchen I
    Prog Neurobiol; 1986; 26(2):119-46. PubMed ID: 3704168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.